ST000389 Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancer (part II) | ||||
Limit by pathway class: | Minimum # of metabolites per pathway: |
ST000389 Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancer (part II) | ||||
Limit by pathway class: | Minimum # of metabolites per pathway: |
![]() |